These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 33461356)

  • 1. Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study.
    Bruin-Weller M; Pink AE; Patrizi A; Gimenez-Arnau AM; Agner T; Roquet-Gravy PP; Ferrucci SM; Arenberger P; Svensson A; Schuttelaar MLA; Nosbaum A; Jayawardena S; Rizova E; Ardeleanu M; Eckert L; Ozturk ZE
    J Dermatolog Treat; 2021 Mar; 32(2):164-173. PubMed ID: 33461356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atopic dermatitis disease registry in Japanese adult patients with moderate to severe atopic dermatitis (ADDRESS-J): Baseline characteristics, treatment history and disease burden.
    Katoh N; Saeki H; Kataoka Y; Etoh T; Teramukai S; Takagi H; Tajima Y; Ardeleanu M; Rizova E; Arima K;
    J Dermatol; 2019 Apr; 46(4):290-300. PubMed ID: 30756423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD).
    de Bruin-Weller M; Pink AE; Ferrucci SM; Patrizi A; Svensson A; Schuttelaar MLA; Tauber M; Ardeleanu M; Jayawardena S; Daoud M
    J Dermatolog Treat; 2022 Aug; 33(5):2565-2570. PubMed ID: 35255779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Gold LS; Desai S; Golant A; DiRuggiero D; Fenske DC; Li A; Dawson Z; Muñoz Maldonado Y; Ho K; Callahan K; Simpson EL
    J Dermatolog Treat; 2024 Dec; 35(1):2396382. PubMed ID: 39322226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study.
    Calzavara-Pinton P; Čelakovská J; Lapeere H; Holzer G; Al-Ahmad M; Chu CY; Ferrucci SM; Kataoka Y; Rossi M; Fomina DS; Chung WH; Tzellos T; Fougerousse AC; Wu J; Ardeleanu M; Ozturk ZE
    Adv Ther; 2023 Dec; 40(12):5366-5382. PubMed ID: 37801232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AtopyReg
    Stingeni L; Chiricozzi A; Calzavara-Pinton P; Napolitano M; Peris K; Schena D; Patruno C; Rossi M; Foti C; Fargnoli MC; Corazza M; Ferrucci SM; Pigatto PD; Romanelli M; Fabbrocini G; Girolomoni G; Passante M; Romita P; Esposito M; Schettini N; Marzano AV; Tonini G; Marietti R; Casciola G; Argenziano G; Hansel K;
    Am J Clin Dermatol; 2024 Jan; 25(1):149-160. PubMed ID: 37725229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A real-world study evaluating adeQUacy of Existing Systemic Treatments for patients with moderate-to-severe Atopic Dermatitis (QUEST-AD): Baseline treatment patterns and unmet needs assessment.
    Wei W; Ghorayeb E; Andria M; Walker V; Schnitzer J; Kennedy M; Chen Z; Belland A; White J; Silverberg JI
    Ann Allergy Asthma Immunol; 2019 Oct; 123(4):381-388.e2. PubMed ID: 31325566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Inadequately Controlled Disease and Disease Severity With Patient-Reported Disease Burden in Adults With Atopic Dermatitis.
    Simpson EL; Guttman-Yassky E; Margolis DJ; Feldman SR; Qureshi A; Hata T; Mastey V; Wei W; Eckert L; Chao J; Arnold RJG; Yu T; Vekeman F; Suárez-Fariñas M; Gadkari A
    JAMA Dermatol; 2018 Aug; 154(8):903-912. PubMed ID: 29971354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2.
    Cork MJ; Eckert L; Simpson EL; Armstrong A; Barbarot S; Puig L; Girolomoni G; de Bruin-Weller M; Wollenberg A; Kataoka Y; Remitz A; Beissert S; Mastey V; Ardeleanu M; Chen Z; Gadkari A; Chao J
    J Dermatolog Treat; 2020 Sep; 31(6):606-614. PubMed ID: 31179791
    [No Abstract]   [Full Text] [Related]  

  • 10. The patient-reported disease burden in adults with atopic dermatitis: a cross-sectional study in Europe and Canada.
    de Bruin-Weller M; Gadkari A; Auziere S; Simpson EL; Puig L; Barbarot S; Girolomoni G; Papp K; Pink AE; Saba G; Werfel T; Eckert L
    J Eur Acad Dermatol Venereol; 2020 May; 34(5):1026-1036. PubMed ID: 31587373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world burden of atopic dermatitis: Austrian and Swiss data from the MEASURE-AD study.
    Darbellay B; Huber M; Bisschoff IJ; Guillod C; Hügel R; Pirkhammer D; Sator PG; Taskesen T; Lang CCV
    J Dermatolog Treat; 2024 Dec; 35(1):2415407. PubMed ID: 39419511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient burden of moderate to severe atopic dermatitis (AD): Insights from a phase 2b clinical trial of dupilumab in adults.
    Simpson EL; Bieber T; Eckert L; Wu R; Ardeleanu M; Graham NM; Pirozzi G; Mastey V
    J Am Acad Dermatol; 2016 Mar; 74(3):491-8. PubMed ID: 26777100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinically Meaningful Responses to Dupilumab in Adolescents with Uncontrolled Moderate-to-Severe Atopic Dermatitis: Post-hoc Analyses from a Randomized Clinical Trial.
    Paller AS; Bansal A; Simpson EL; Boguniewicz M; Blauvelt A; Siegfried EC; Guttman-Yassky E; Hultsch T; Chen Z; Mina-Osorio P; Lu Y; Rossi AB; He X; Kamal M; Graham NMH; Pirozzi G; Ruddy M; Eckert L; Gadkari A
    Am J Clin Dermatol; 2020 Feb; 21(1):119-131. PubMed ID: 31823222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ).
    de Bruin-Weller M; Thaçi D; Smith CH; Reich K; Cork MJ; Radin A; Zhang Q; Akinlade B; Gadkari A; Eckert L; Hultsch T; Chen Z; Pirozzi G; Graham NMH; Shumel B
    Br J Dermatol; 2018 May; 178(5):1083-1101. PubMed ID: 29193016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
    Artime E; Serra E; Mert C; Díaz-Cerezo S; Huete T; Hernández-Subirá I; Lledo-Bryant L; Sicras-Mainar A
    Actas Dermosifiliogr; 2023 Jan; 114(1):T9-T18. PubMed ID: 36368579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-World Treatment Patterns, Resource Use and Costs in Adult Patients With Atopic Dermatitis Receiving Systemic Treatment: Derma-Atopic Study in Spain.
    Artime E; Serra E; Mert C; Díaz-Cerezo S; Huete T; Hernández-Subirá I; Lledo-Bryant L; Sicras-Mainar A
    Actas Dermosifiliogr; 2023 Jan; 114(1):9-18. PubMed ID: 36030827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wet-wrap therapy with halometasone cream for severe adult atopic dermatitis.
    Xu W; Li Y; Chen Z; Liu T; Wang S; Li L
    Postgrad Med; 2018 Jun; 130(5):470-476. PubMed ID: 29768078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease burden among patients with atopic dermatitis treated with systemic therapy for 4-12 months: results from the CorEvitas Atopic Dermatitis Registry.
    Silverberg JI; Pierce E; Feely M; Atwater AR; Schrader A; Jones EA; Dave SS; Simpson EL
    J Dermatolog Treat; 2023 Dec; 34(1):2246601. PubMed ID: 37691405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal course and phenotypes of health-related quality of life in adults with atopic dermatitis.
    Schwartzman G; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
    Clin Exp Dermatol; 2022 Feb; 47(2):359-372. PubMed ID: 34623642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical phenotyping of atopic dermatitis using combined itch and lesional severity: A prospective observational study.
    Chovatiya R; Lei D; Ahmed A; Chavda R; Gabriel S; Silverberg JI
    Ann Allergy Asthma Immunol; 2021 Jul; 127(1):83-90.e2. PubMed ID: 33819616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.